Gastric carcinoma (n = 31) | Esophageal carcinoma (n = 17) | Total (n = 48) | |
---|---|---|---|
Type of surgery | |||
Esophagectomy | 1 (3%) | 15 (88%) | 16 (33%) |
Gastrectomy | 30 (97%) | 2 (12%) | 32 (66%) |
HIPEC | 14 (45%) | 1 (6%) | 15 (31%) |
Additional resection | |||
None | 10 (32%) | 5 (29%) | 15 (31%) |
Peritoneum | 16 (51%) | 2 (12%) | 18 (37%) |
Distant lymph nodes | 1 (3%) | 3 (18%) | 4 (8%) |
Liver | 1 (3%) | 3 (18%) | 4 (8%) |
Adrenal | 3 (10%) | 0 | 3 (6%) |
Multivisceral resection | 0 | 4 (24%) | 4 (8%) |
Perioperative in-patient stay in days | 11 (8–23) | 14 (7–94) | 12 (7–94) |
Perioperative in intensive care in days | 4 (2–11) | 5 (3–22) | 4 (2–22) |
Perioperative complications | |||
Clavien Dindo | 13 (42%) | 10 (59%) | 23 (48%) |
I/II | 9 (29%) | 7 (41%) | 16 (33%) |
III/IV | 3 (10%) | 1 (6%) | 4 (8%) |
V | 1 (3%) | 2 (12%) | 3 (6%) |
Resection margin | |||
R0 | 21 (68%) | 12 (70%) | 33 (69%) |
R1 (primary tumor) | 3 (9%) | 1 (6%) | 4 (8%) |
R2 (non-resected metastases) | 7 (22%) | 4 (23%) | 11 (23%) |
Postoperative residual tumor | |||
Local | 3 (10%) | 1 (6%) | 4 (8%) |
Peritoneal carcinomatosis | 3 (10%) | 2 (12%) | 5 (10%) |
Lymph nodes | 1 (3%) | 2 (12%) | 3 (6%) |
Distant metastasis | 3 (10%) | 0 | 3 (6%) |
Recurrence | 12 (39%) | 7 (41%) | 19 (40%) |
Time of recurrence after surgery in months* | 5,5 (1–15) | 6,5 (1–10) | 6 (1–15) |
Type of recurrence | |||
Local | 1 (8%) | 0 | 1 (5%) |
Local and distant | 2 (17%) | 2 (29%) | 4 (21%) |
Peritoneal carcinomatosis | 4 (33%) | 1 (14%) | 5 (26%) |
Hepatic metastasis | 3 (25%) | 3 (43%) | 6 (32%) |
Other type of metastasis | 1 (8%) | 1 (14%) | 2 (11%) |